- Home
- COKE vs RADX Comparison
COKE vs RADX Comparison
Compare COKE & RADX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COKE
- RADX
- Stock Information
- Founded
- COKE 1980
- RADX 2021
- Country
- COKE United States
- RADX Australia
- Employees
- COKE N/A
- RADX N/A
- Industry
- COKE Beverages (Production/Distribution)
- RADX
- Sector
- COKE Consumer Staples
- RADX
- Exchange
- COKE Nasdaq
- RADX NYSE
- Market Cap
- COKE 12.3B
- RADX 11.4B
- IPO Year
- COKE N/A
- RADX N/A
- Fundamental
- Price
- COKE $1,382.86
- RADX $4.68
- Analyst Decision
- COKE
- RADX
- Analyst Count
- COKE 0
- RADX 0
- Target Price
- COKE N/A
- RADX N/A
- AVG Volume (30 Days)
- COKE 36.9K
- RADX 33.6K
- Earning Date
- COKE 02-20-2025
- RADX 02-26-2025
- Dividend Yield
- COKE 0.72%
- RADX N/A
- EPS Growth
- COKE 60.76
- RADX N/A
- EPS
- COKE 70.04
- RADX N/A
- Revenue
- COKE $6,899,716,000.00
- RADX $1,306,729.00
- Revenue This Year
- COKE N/A
- RADX N/A
- Revenue Next Year
- COKE N/A
- RADX N/A
- P/E Ratio
- COKE $19.75
- RADX N/A
- Revenue Growth
- COKE 3.69
- RADX N/A
- 52 Week Low
- COKE $800.76
- RADX $3.55
- 52 Week High
- COKE $1,460.92
- RADX $50.82
- Technical
- Relative Strength Index (RSI)
- COKE 52.02
- RADX N/A
- Support Level
- COKE $1,384.48
- RADX N/A
- Resistance Level
- COKE $1,451.78
- RADX N/A
- Average True Range (ATR)
- COKE 47.01
- RADX 0.00
- MACD
- COKE -1.95
- RADX 0.00
- Stochastic Oscillator
- COKE 41.81
- RADX 0.00
About COKE Coca-Cola Consolidated Inc.
Coca-Cola Consolidated Inc sells nonalcoholic beverage products in the United States. The company purchases concentrate and syrups from other beverage manufacturers under a license, then produces, packages, markets, and distributes the beverages to retailers. The company's primary licensor is Coca-Cola Co., which generally allows it to exclusively market, produce, and distribute Coca-Cola products in specified parts of the U.S.: North Carolina, South Carolina, West Virginia, and parts of Alabama, Georgia, Tennessee, Virginia, Indiana, and Kentucky. The company manages its business in two operating segments. Nonalcoholic Beverages segment which represents the majority of the company's revenues and All Other segments.
About RADX RADIOPHARM THERANOSTICS LIMITED SPON ADS EACH REP 300 ORD
Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies.